Mu rugendo rwo kugera ku buremere buzira umuze, abantu benshi usanga bashakisha inzira zirenze imirire no gukora siporo. Iterambere ry'ubumenyi bwubuvuzi ryatangije imiti ishobora gufasha kugabanya ibiro , bitanga ibyiringiro bishya kubahanganye numubyibuho ukabije. Imiti ibiri nkiyi, Wegovy na Saxenda, imaze kwitabwaho neza. Gusobanukirwa itandukaniro ninyungu zabo nibyingenzi muguhitamo neza.
Iyi miti yombi yemejwe na FDA kandi iteganijwe gushyigikira kugabanya ibiro kubantu bakuze bafite umubyibuho ukabije cyangwa abantu bafite ibiro byinshi bafite ubuzima bujyanye n'uburemere. Mugihe ubushake bwo kuvura bugenda bwiyongera, niko gukenera gusobanukirwa uburyo buri miti ikora kandi ishobora kuba nziza kubyo umuntu akeneye.
Wegovy na Saxenda ni imiti ibiri yatewe inshinge zagenewe gufasha kugabanya ibiro, buriwese ufite imiterere nuburyo bwihariye, kandi guhitamo igikwiye biterwa nimpamvu zubuzima bwite nintego zihariye zo kugabanya ibiro.
Gusobanukirwa Wegovy na Saxenda
Wegovy (semaglutide) na Saxenda (liraglutide) bari mubyiciro byibiyobyabwenge bizwi nka GLP-1 reseptor agonist. Bigana imisemburo glucagon imeze nka peptide-1, igira uruhare mu kugaburira ibyifuzo no gufata ibiryo. Nubwo bisa, iyi miti ifite itandukaniro ritandukanye muburyo bwabo, dosiye, hamwe ninshuro zubuyobozi.
Wegovy irimo semaglutide, ikomatanyirizo ryakozwe mbere yo kuvura diyabete yo mu bwoko bwa 2 ku izina rya Ozempic. Wegovy yateguwe muburyo bwo gucunga ibiro kandi itangwa rimwe mucyumweru hakoreshejwe inshinge. Kwemeza kugabanya ibiro bishingiye kubigeragezo bivura byerekana kugabanya ibiro mubitabiriye amahugurwa.
Ku rundi ruhande, Saxenda irimo liraglutide, nayo ikoreshwa mu kurwanya glycemic muri diyabete ku izina rya Victoza. Mu rwego rwo kugabanya ibiro, Saxenda yandikiwe ku kigero cyo hejuru kandi itangwa buri munsi binyuze mu gutera inshinge. Saxenda yemejwe mbere ya Wegovy kandi imaze imyaka myinshi ikoreshwa cyane.
Itandukaniro rimwe ryingenzi hagati yimiti yombi ningengabihe ya dosiye. Inshinge ya Wegovy inshuro imwe mucyumweru irashobora gutanga uburyo bworoshye ugereranije ninshinge za buri munsi zisabwa na Saxenda. Iri tandukaniro rishobora kugira ingaruka ku gukurikiza gahunda yimiti no guhaza abarwayi muri rusange.
Gusobanukirwa itandukaniro ryibanze ningirakamaro mugihe usuzumye iyi miti. Ibintu nko gukuramo inshuro, kumenyera inshinge, hamwe nubuzima bishobora guhindura amahitamo hagati ya Wegovy na Saxenda.
Uburyo bukoreshwa gute?
Mugihe imiti yombi ari GLP-1 reseptor agonist, iratandukanye gato mumiterere ya molekile nuburyo bigira ingaruka kumubiri. GLP-1 ni imisemburo itera gusohora insuline, ikabuza gusohora glucagon, igabanya umuvuduko wa gastrica, kandi ikongera guhaga - ibyo byose bigira uruhare mu kugabanya ibiro.
Wegovy (semaglutide) ifite ubuzima burebure burenze igice cya Saxenda (liraglutide), ikemerera gutangwa rimwe mu cyumweru. Semaglutide ihuza reseptor ya GLP-1 ifitanye isano ryinshi, biganisha ku ngaruka zigaragara ku guhagarika ubushake bwo kurya no kugabanya ibiryo.
Saxenda ikora kimwe ariko isaba ubuyobozi bwa buri munsi kubera igihe gito cyibikorwa. Liraglutide nayo itinda gusiba gastric kandi ikongerera guhaga, ariko ingaruka zayo zirashobora kutagumaho ugereranije na semaglutide.
Iyi miti yombi ntabwo ifasha mu kugabanya ibiro gusa ahubwo inagira ingaruka nziza kumpanuka ziterwa numutima. Zishobora kuzamura umuvuduko wamaraso, urugero rwa cholesterol, hamwe no kurwanya glycemic, bifasha cyane cyane abantu bafite ibibazo byubuzima bw’umubyibuho ukabije.
Kumva uburyo iyi miti ikora irashobora gufasha abarwayi nabashinzwe ubuzima gufata ibyemezo byuzuye. Itandukaniro rya farumasi iri hagati ya semaglutide na liraglutide irashobora kugira ingaruka nziza kandi ikwiranye nabarwayi kugiti cyabo.
Ingaruka no Gutakaza Ibiro Ibisubizo
Igeragezwa rya Clinical ryerekanye ko Wegovy na Saxenda zombi zifite akamaro kuri kugabanya ibiro iyo uhujwe nubuzima bwimibereho nko kurya no gukora siporo. Ariko, hariho itandukaniro rigaragara muburyo bwo kugabanya ibiro byagaragaye hamwe na buri miti.
Ubushakashatsi bwerekanye ko abarwayi bakoresha Wegovy bashobora kugabanuka cyane ugereranije n’abakoresha Saxenda. Mu bigeragezo by’amavuriro, abitabiriye gufata Wegovy bagabanutse ku kigereranyo cya 15% by’ibiro by’umubiri mu byumweru 68, mu gihe abafata Saxenda batakaje hafi 5% kugeza 10% mu byumweru 56.
Ingaruka nini ya Wegovy irashobora kwitirirwa imbaraga zayo nyinshi nibikorwa birebire. Kugabanya ibiro byinshi byagezweho hamwe na Wegovy byabaye ikintu cyingenzi mu kwamamara kwabo mu barwayi bashaka kugabanya ibiro.
Nyamara, ibisubizo bya buri muntu birashobora gutandukana bitewe nibintu byinshi, harimo kubahiriza gahunda yimiti, impinduka zubuzima, nubuzima bwumuntu. Ni ngombwa ko abarwayi bashiraho ibyifuzo bifatika kandi bagakorana cyane nabashinzwe ubuzima.
Ubwanyuma, mugihe Wegovy ishobora gutanga ibiro byinshi ugereranije, Saxenda ikomeza kuba amahitamo meza, cyane cyane kubantu bashobora guhitamo kunywa buri munsi cyangwa bafite ibitekerezo byubuzima bituma bahitamo neza.
Ingaruka Zuruhande no Gutekereza kumutekano
Kimwe n'imiti yose, Wegovy na Saxenda bazanye ingaruka zishobora kuba abarwayi bagomba kumenya. Ingaruka zikunze kugaragara ku miti yombi zirimo ibimenyetso byo mu gifu nko kugira isesemi, kuruka, impiswi, kuribwa mu nda, no kubabara mu nda.
Izi ngaruka mbi zigaragara cyane mugitangira cyo kuvura kandi zishobora kugabanuka uko umubiri umenyereye imiti. Kwiyongera gahoro gahoro nkuko byateganijwe nushinzwe ubuvuzi birashobora gufasha kugabanya izo ngaruka.
Ingaruka zikomeye ntizisanzwe ariko zirashobora kuba zirimo pancreatitis, indwara ya gallbladder, nibibazo byimpyiko. Iyi miti yombi itanga umuburo ku byago bishobora gutera kanseri ya tiroyide C-selile, ishingiye ku bushakashatsi bwakozwe ku nzoka, nubwo ibi bitaremezwa mu bantu.
Abarwayi bafite amateka yihariye cyangwa yumuryango yubwoko bumwe na bumwe bwa kanseri ya tiroyide cyangwa syndrome ya endocrine neoplasia nyinshi ubwoko bwa 2 ntibagomba gukoresha iyi miti. Ni ngombwa kuganira neza amateka yubuvuzi nushinzwe ubuzima mbere yo gutangira kwivuza.
Gukurikirana ninzobere mu by'ubuzima ni ngombwa kugira ngo iyi miti ikoreshwe neza. Gukurikirana buri gihe birashobora gufasha gucunga ingaruka mbi zose no guhindura imiti nkuko bikenewe.
Guhitamo neza: Wegovy cyangwa Saxenda?
Guhitamo hagati ya Wegovy na Saxenda bikubiyemo gusuzuma ibintu byinshi, birimo gukora neza, ingaruka mbi, kuborohereza, hamwe nubuzima bwa buri muntu.
Wegovy irashobora kuba amahitamo yatoranijwe kubashaka kugabanya ibiro byinshi no korohereza kunywa rimwe mu cyumweru. Ingaruka zikomeye zo kugabanya ibiro zirashobora gutera inkunga abarwayi bahanganye nibindi bikorwa.
Saxenda irashobora kuba nziza kubantu bakunda kumenyera kunywa buri munsi cyangwa bashobora kwitabira neza liraglutide bitewe nubuzima bwabo bwite. Ifite imiterere yumutekano yashizweho kuva imyaka ikoreshwa.
Ibiciro n'ubwishingizi birashobora kandi guhindura umwanzuro. Imiti yombi irashobora kuba ihenze, kandi gahunda yubwishingizi irashobora kugira politiki zitandukanye zo gukwirakwiza. Abarwayi bagomba kugisha inama abatanga ubwishingizi kandi birashoboka ko bashakisha gahunda zifasha abarwayi mugihe bikenewe.
Ubwanyuma, icyemezo kigomba gufatwa kubufatanye nubuvuzi bushobora gusuzuma amateka yubuvuzi bwumuntu, intego zo kugabanya ibiro, hamwe nibyifuzo byo gutanga imiti ikwiye.
Umwanzuro
Mu gusoza, Wegovy na Saxenda batanga uburyo bwiza bwo kuvura kugabanya ibiro, buri kimwe gifite inyungu zacyo. Wegovy ikora neza hamwe no kuyikoresha buri cyumweru bituma ihitamo neza kuri benshi, mugihe Saxenda yakoresheje hamwe na gahunda ya buri munsi irashobora guhuza nabandi.
Gusobanukirwa itandukaniro riri hagati yiyi miti ningirakamaro kubarwayi batangiye urugendo rwo kugabanya ibiro. Urebye ibintu nkibikorwa byiza, ingaruka mbi, ibyifuzo byawe, hamwe nubuzima bwumuntu ku giti cye, abantu barashobora gukorana nabashinzwe ubuzima kugirango bahitemo amahitamo akwiranye nibyo bakeneye.
Kugabanya ibiro ni urugendo rwawe kandi akenshi rutoroshye. Hamwe no kubona imiti nka Wegovy na Saxenda, hari ibikoresho byinshi kuruta ikindi gihe cyose cyo gufasha abantu kugera kuntego zabo zubuzima. Gushyikirana kumugaragaro ninzobere mu buvuzi no kwiyemeza guhindura imibereho ni ibintu byingenzi bigize intsinzi.
Ibibazo
Ikibazo: Nshobora kuva muri Saxenda nkajya muri Wegovy niba ntabona ibisubizo byifuzwa?
Igisubizo: Yego, ariko impinduka zose kumiti zigomba gukorwa ziyobowe nubuvuzi.
Ikibazo: Ese Wegovy na Saxenda bafite ubwishingizi?
Igisubizo: Igipfukisho kiratandukanye na gahunda yubwishingizi; ugomba kugenzura nuwaguhaye kugirango wumve inyungu zawe.
Ikibazo: Nkeneye gukurikiza indyo yihariye mugihe mfata iyi miti?
Igisubizo: Kugaburira ibiryo bya calorie no kongera imyitozo ngororamubiri birasabwa kongera imikorere yimiti yombi.
Ikibazo: Nshobora kumara igihe kingana iki kuri Wegovy cyangwa Saxenda?
Igisubizo: Igihe cyo kwivuza kigomba kugenwa nushinzwe ubuvuzi ukurikije iterambere ryibiro byawe hamwe nubuzima.
Ikibazo: Bigenda bite iyo mbuze igipimo cyimiti yanjye?
Igisubizo: Kurikiza amabwiriza yatanzwe nubuvuzi bwawe cyangwa umuyobozi wimiti; hamagara uwaguhaye niba udashidikanya.
Ikibazo: Byagenda bite niba ndi allergic kuri Wegovy (semaglutide)?
Igisubizo: Mubyukuri, amavuriro amwe n'amwe yatangaje ko abarwayi bafite ibibazo bya allergique kuri semaglutide. Niba uri allergic kuri semaglutide, urashobora gutekereza OTESALY FAT-X nkubundi buryo. OTESALY FAT-X ikoresha acetyl hexapeptide-39, ikora mu buryo butandukanye na GLP-1 agoniste ariko ikaba yerekanye ingaruka zitanga ikizere mu kurwanya ubushake bwo kurya no gucunga ibiro. Benshi mubakiriya bacu basangiye ko mugihe bari allergic kuri semaglutide, babonye ibisubizo byiza hamwe na OTESALY FAT-X nta reaction ya allergique. Ku barwayi badashobora kwihanganira semaglutide, OTESALY FAT-X itanga amahitamo yihariye kandi meza.
Ikibazo: Wegovy na Saxenda birahenze cyane. Hariho ubundi buryo buhendutse bushoboka?
Igisubizo: Niba ushaka uburyo buhendutse bwo gukoresha ibiro, OTESALY FAT-X ikwiye kubitekerezaho. Ugereranije na GLP-1 agoniste, OTESALY FAT-X itanga igiciro cyiza kandi yakoreshejwe cyane kumasoko yisi, cyane cyane muri Amerika n'Uburayi, aho yakiriye ibitekerezo byiza kubakoresha. OTESALY FAT-X ikora neza mugushyigikira gucunga ibiro, bigatuma ihitamo neza kubafite imbogamizi zingengo yimari bagishaka inkunga yibiro byiza. Niba ubishaka, wumve neza twandikire kugirango umenye byinshi kubijyanye no kugura nuburyo bworoshye bwo kohereza.
